Stay updated with breaking news from Q Gen Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A 'supercharged' version of QIMR Berghofer's CMV-specific T cell immunotherapy for brain cancer has advanced to a phase 1 clinical trial with CUREator funding.
ASX Health Stocks: Emyria on a high after getting ethics approval, Twiggy’s investment
QIMR Berghofer Medical Research Institute will work with San-Francisco-based company, Cellevolve Bio to develop and manufacture cellular